Evolent Health [EVH] vs Omnicell [OMCL] Detailed Stock Comparison

Evolent Health Inc.

NYSE
Loading...

Omnicell Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Evolent Health Inc. wins in 5 metrics, Omnicell Inc. wins in 13 metrics, with 1 ties. Omnicell Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Evolent Health Inc. Omnicell Inc. Better
P/E Ratio (TTM) -0.58 918.75 Omnicell Inc.
Price-to-Book Ratio 0.85 1.34 Evolent Health Inc.
Debt-to-Equity Ratio 238.37 16.59 Omnicell Inc.
PEG Ratio 0.00 -8.01 Tie
EV/EBITDA 13.48 36.82 Evolent Health Inc.
Profit Margin (TTM) -28.49% 0.17% Omnicell Inc.
Operating Margin (TTM) -2.06% 2.20% Omnicell Inc.
EBITDA Margin (TTM) N/A 2.20% N/A
Return on Equity -66.54% 0.17% Omnicell Inc.
Return on Assets (TTM) -0.13% 0.36% Omnicell Inc.
Free Cash Flow (TTM) $4.76M $69.37M Omnicell Inc.
1-Year Return -41.96% 29.33% Omnicell Inc.
Price-to-Sales Ratio (TTM) 0.19 1.41 Evolent Health Inc.
Enterprise Value $1.19B $1.68B Omnicell Inc.
EV/Revenue Ratio 0.63 1.42 Evolent Health Inc.
Gross Profit Margin (TTM) 20.75% 41.51% Omnicell Inc.
Revenue per Share (TTM) $16 $26 Omnicell Inc.
Earnings per Share (Diluted) $-5.07 $0.04 Omnicell Inc.
Beta (Stock Volatility) 0.37 0.86 Evolent Health Inc.
Short % of Float 14.47% 6.68% Omnicell Inc.

Evolent Health Inc. vs Omnicell Inc. Stock Performance Analysis

Loading Price Chart...

EVH
OMCL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Evolent Health Inc.-2.08%0.86%18.69%55.63%14.08%20.82%
Omnicell Inc.5.71%-4.67%-7.26%16.62%-7.58%-11.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Evolent Health Inc.-41.96%-83.22%-75.66%-70.50%-74.55%-74.55%
Omnicell Inc.29.33%-47.23%-73.67%16.01%151.70%181.05%

Performance & Financial Health Analysis: Evolent Health Inc. vs Omnicell Inc.

MetricEVHOMCL
Market Information
Market Cap i$329.33M$1.65B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,779,287390,030
90 Day Avg. Volume i2,982,706505,763
Last Close$4.70$39.99
52 Week Range$2.10 - $12.06$26.85 - $55.00
% from 52W High-61.04%-27.29%
All-Time High$39.78 (Sep 12, 2022)$187.29 (Nov 22, 2021)
% from All-Time High-88.19%-78.65%
Growth Metrics
Quarterly Revenue Growth-0.28%0.02%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i-0.28%0.00%
Operating Margin (TTM) i-0.02%0.02%
Return on Equity (TTM) i-0.67%0.00%
Debt to Equity (MRQ) i238.3716.59
Cash & Liquidity
Book Value per Share (MRQ)$3.72$27.36
Cash per Share (MRQ)$1.36$4.33
Operating Cash Flow (TTM) i$38.84M$127.30M
Levered Free Cash Flow (TTM) i$98.41M$94.53M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Evolent Health Inc. vs Omnicell Inc.

MetricEVH (Apr 24, 2026)OMCL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-0.58918.75
Forward P/E i7.1317.60
PEG Ratio i0.00-8.01
Price to Sales (TTM) i0.191.41
Price to Book (MRQ) i0.851.34
Market Capitalization
Market Capitalization i$329.33M$1.65B
Enterprise Value i$1.19B$1.68B
Enterprise Value Metrics
Enterprise to Revenue i0.631.42
Enterprise to EBITDA i13.4836.82
Risk & Other Metrics
Beta i0.370.86
Book Value per Share (MRQ) i$3.72$27.36

Financial Statements Comparison: Evolent Health Inc. vs Omnicell Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEVH (2025)OMCL (2025)
Revenue/Sales i1.88B1.18B
Cost of Goods Sold i1.48B681.40M
COGS % of Revenue i78.7%57.5%
Gross Profit i399.88M503.44M
Gross Margin i21.3%42.5%
Research & Development iN/A88.67M
Operating Income (EBIT) i-19.83M5.16M
Operating Margin i-1.1%0.4%
EBITDA i85.02M91.79M
EBITDA Margin i4.5%7.7%
Pre-Tax Income i-534.64M11.33M
Pre-Tax Income % of Revenue i-28.5%1.0%
Income Tax i-126,0009.27M
Income Tax % of Revenue i0.0%0.8%
Net Income (Profit) i-534.51M2.05M
Profit Margin i-28.5%0.2%

Balance Sheet & Liquidity Metrics

MetricEVH (2025)OMCL (2025)
Cash & Equivalents i151.86M196.52M
Total Current Assets i506.37M680.07M
Total Current Assets % of Revenue i27.0%57.4%
Total Current Liabilities i385.26M476.61M
Total Current Liabilities % of Revenue i20.5%40.2%
Long-Term Debt i974.36M192.39M
Long-Term Debt % of Revenue i51.9%16.2%
Total Shareholders Equity i415.19M1.23B
Retained Earnings i-1.32B384.94M
Retained Earnings % of Revenue i-70.1%32.5%
Property, Plant & Equipment i4.37M128.44M

Cash Flow Statement Comparison

MetricEVH (2025)OMCL (2025)
Operating Cash Flow i-425.17M155.13M
Operating Cash Flow % of Revenue i-22.7%13.1%
Capital Expenditures iN/A-40.42M
Free Cash Flow i4.76M69.37M
FCF Margin i0.3%5.9%
Debt Repayment i-342.98M-175.00M
Common Stock Repurchase i-40.00M-77.60M

Short Interest & Institutional Ownership Analysis

MetricEVHOMCL
Shares Short i15.95M2.50M
Short Ratio i5.144.16
Short % of Float i14.47%6.68%
Shares Outstanding i111.63M45.03M
Float Shares i92.79M41.91M
% Held by Insiders i1.62%2.20%
% Held by Institutions i110.52%106.39%
% Held by Public i-12.14%-8.59%

Dividend Analysis & Yield Comparison: Evolent Health Inc. vs Omnicell Inc.

MetricEVHOMCL
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A